MHC-I-restricted melanoma antigen specific TCR-engineered human CD4+ T cells exhibit multifunctional effector and helper responses, in vitro.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Clinical Immunology

• Publication date

  2010-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.clim.2010.04.013PMID 20547105PMCID PMC2917536
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tumor-reactive CD4+ T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts

  2010cited by this paper
• Naive tumor-specific CD4+ T cells differentiated in vivo eradicate established melanoma

  2010cited by this paper
• Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen.

  2009cited by this paper
• Obstacles to and opportunities for more effective peptide-based therapeutic immunization in human melanoma.

  2009cited by this paper
• MHC class I TCR engineered anti-tumor CD4 T cells: implications for cancer immunotherapy.

  2009cited by this paper
• CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit

  2008cited by this paper
• Frontline : Polyfunctional T cell responses are a hallmark of HIV-2 infection

  2008cited by this paper
• CD4+CD25− T Cells Transduced to Express MHC Class I-Restricted Epitope-Specific TCR Synthesize Th1 Cytokines and Exhibit MHC Class I-Restricted Cytolytic Effector Function in a Human Melanoma Model1

  2008cited by this paper
• Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens.

  2008cited by this paper
• T-cell quality in memory and protection: implications for vaccine design

  2008cited by this paper
• Gene Transfer of Tumor-Reactive TCR Confers Both High Avidity and Tumor Reactivity to Nonreactive Peripheral Blood Mononuclear Cells and Tumor-Infiltrating Lymphocytes1

  2006cited by this paper
• Generation of T Cell Help through a MHC Class I-Restricted TCR1

  2006cited by this paper
• CD8 alpha coreceptor to improve TCR gene transfer to treat melanoma: down-regulation of tumor-specific production of IL-4, IL-5, and IL-10.

  2006influential reference
• Influence of human CD8 on antigen recognition by T-cell receptor-transduced cells.

  2006cited by this paper
• CD8α Coreceptor to Improve TCR Gene Transfer to Treat Melanoma: Down-Regulation of Tumor-Specific Production of IL-4, IL-5, and IL-10

  2006cited by this paper
• Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes

  2006cited by this paper
• A critical role of T cell antigen receptor-transduced MHC class I-restricted helper T cells in tumor protection

  2005cited by this paper
• Generation of tumor-specific, HLA class I-restricted human Th1 and Tc1 cells by cell engineering with tumor peptide-specific T-cell receptor genes.

  2005cited by this paper
• Simultaneous generation of CD8+ and CD4+ melanoma-reactive T cells by retroviral-mediated transfer of a single T-cell receptor.

  2005cited by this paper
• Redirecting human CD4+ T lymphocytes to the MHC class I-restricted melanoma antigen MAGE-A1 by TCR alphabeta gene transfer requires CD8alpha.

  2005cited by this paper
• CD4+ T Lymphocytes: A Critical Component of Antitumor Immunity

  2005cited by this paper
• Redirecting human CD4+ T lymphocytes to the MHC class I-restricted melanoma antigen MAGE-A1 by TCR αβ gene transfer requires CD8α

  2005cited by this paper
• Cross‐presentation of a human tumor antigen delivered to dendritic cells by HSV VP22‐mediated protein translocation

  2004cited by this paper
• T-cell-based immunotherapy of melanoma: what have we learned and how can we improve?

  2004cited by this paper
• Helping the CD8+ T-cell response

  2004cited by this paper
• High Efficiency TCR Gene Transfer into Primary Human Lymphocytes Affords Avid Recognition of Melanoma Tumor Antigen Glycoprotein 100 and Does Not Alter the Recognition of Autologous Melanoma Antigens

  2003cited by this paper
• CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes

  2003cited by this paper
• Regulation of melanoma epitope-specific cytolytic T lymphocyte response by immature and activated dendritic cells, in vitro.

  2003cited by this paper
• Analysing cell division in vivo and in vitro using flow cytometric measurement of CFSE dye dilution.

  2000cited by this paper
• Efficient transfer of a tumor antigen-reactive TCR to human peripheral blood lymphocytes confers anti-tumor reactivity.

  1999cited by this paper
• CD4 T Cells and Their Role in Antitumor Immune Responses

  1999cited by this paper
• Vaccination of melanoma patients with peptide- or tumorlysate-pulsed dendritic cells

  1998cited by this paper
• The role of CD4+ T cell responses in antitumor immunity.

  1998cited by this paper
• Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGES‐3

  1995cited by this paper
• Helper activity is required for the in vivo generation of cytotoxic T lymphocytes

  1982cited by this paper

• Single-Cell Transcriptomics Reveals Killing Mechanisms of Antitumor Cytotoxic CD4+ TCR-T Cells

  2022cites this paper
• The ATG8 Family Proteins GABARAP and GABARAPL1 Target Antigen to Dendritic Cells to Prime CD4+ and CD8+ T Cells

  2022cites this paper
• Adoptive cell therapy with tumor-specific Th9 cells induces viral mimicry to eliminate antigen-loss-variant tumor cells.

  2021cites this paper
• Green Synthesis of Copper Oxide Nanoparticles using Cucumis sativus (cucumber) Extracts and their Bio-physical and Biochemical Characterization for Cosmetic and Dermatologic Applications.

  2020cites this paper
• Recent progress in supramolecular peptide assemblies as virus mimics for cancer immunotherapy.

  2020cites this paper
• CRISPR-mediated deletion of the Protein tyrosine phosphatase, non-receptor type 22 (PTPN22) improves human T cell function for adoptive T cell therapy

  2020cites this paper
• Recent Advances in Targeting CD8 T-Cell Immunity for More Effective Cancer Immunotherapy

  2018cites this paper
• NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives

  2018cites this paper
• Critical biological parameters modulate affinity as a determinant of function in T-cell receptor gene-modified T-cells

  2017cites this paper
• Human Dendritic Cell–Derived Induced Pluripotent Stem Cell Lines Are Not Immunogenic

  2017cites this paper
• Relationship between T-cell receptor beta chain sequences and human cytomegalovirus infection in allogeneic hematopoietic stem cell transplant recipients.

  2017cites this paper
• Classification of current anticancer immunotherapies

  2017cites this paper
• Adaptive Resistance to Cancer Immunotherapy.

  2017cites this paper
• Activation induced cell death (AICD) of human melanoma antigen-specific TCR engineered CD8 T cells involves JNK, Bim and p53

  2017influential citation
• Coupling of HIV-1 Antigen to the Selective Autophagy Receptor SQSTM1/p62 Promotes T-Cell-Mediated Immunity

  2016cites this paper
• PD-1 inhibition and treatment of advanced melanoma-role of pembrolizumab.

  2016cites this paper
• Suppression of inducible CD4 regulatory cells by MHC class I-restricted human tumor epitope specific TCR engineered multifunctional CD4 T cells.

  2016cites this paper
• Human leucocyte antigen class I‐redirected anti‐tumour CD4+ T cells require a higher T cell receptor binding affinity for optimal activity than CD8+ T cells

  2016cites this paper
• Strategies to genetically engineer T cells for cancer immunotherapy

  2016cites this paper
• Influence of Antigen Receptor Avidity, Affinity, and Specificity on Genetically Engineered T Cells

  2015cites this paper
• Knockdown of T‐bet expression in Mart‐127–35‐specific T‐cell‐receptor‐engineered human CD4+ CD25− and CD8+ T cells attenuates effector function

  2015cites this paper
• T‐cell receptor gene therapy — ready to go viral?

  2015cites this paper
• Trial Watch: Adoptive cell transfer for oncological indications

  2015cites this paper
• T-cell receptor gene therapy e ready to go viral? 5

  2015cites this paper
• Concurrent interaction of DCs with CD4+ and CD8+ T cells improves secondary CTL expansion: It takes three to tango

  2014cites this paper
• Classification of current anticancer immunotherapies

  2014cites this paper
• Trial Watch

  2014cites this paper
• Transcriptional Profiles of Mart-1(27-35) Epitope Specific TCReng Human CD8+ and CD4+ T Cells upon Epitope Encounter as Elucidated by RNASeq

  2014influential citation
• Death Receptor–Independent Activation-Induced Cell Death in Human Melanoma Antigen–Specific MHC Class I–Restricted TCR-Engineered CD4 T Cells

  2013cites this paper
• Chimeric antigen receptor-redirected T cells display multifunctional capacity and enhanced tumor-specific cytokine secretion upon secondary ligation of chimeric receptor.

  2013cites this paper
• Analyses of T cell-mediated immune response to a human melanoma-associated antigen by the young and the elderly.

  2013cites this paper
• Characterization of the human CD4+ T‐cell repertoire specific for major histocompatibility class I‐restricted antigens

  2013cites this paper
• Engineering Anti-Tumor T Cell Immunity

  2013cites this paper
• Trial Watch

  2013cites this paper
• Immunology of melanoma.

  2013cites this paper
• HLA-DPB1*05: 01-restricted WT1332-specific TCR-transduced CD4+ T Lymphocytes Display a Helper Activity for WT1-specific CTL Induction and a Cytotoxicity Against Leukemia Cells

  2013cites this paper
• CD8 co-receptor modifications to enhance T cell immunotherapy

  2013cites this paper
• Role of T Cell Receptor Affinity in the Efficacy and Specificity of Adoptive T Cell Therapies

  2013cites this paper
• Restricted TCR-Engineered CD4 T Cells - Specific MHC Class I - Melanoma Antigen Activation-Induced Cell Death in Human Independent - Death Receptor

  2013cites this paper
• Skewed T-cell receptor beta chain variable gene (TCRBV) usage among different clinical types of patients with chronic HBV infection.

  2012cites this paper
• Aurora kinase A-specific T-cell receptor gene transfer redirects T lymphocytes to display effective antileukemia reactivity.

  2012cites this paper
• Challenges in T cell receptor gene therapy

  2012influential citation
• Abrogation of Src Homology Region 2 Domain-Containing Phosphatase 1 in Tumor-Specific T Cells Improves Efficacy of Adoptive Immunotherapy by Enhancing the Effector Function and Accumulation of Short-Lived Effector T Cells In Vivo

  2012cites this paper
• Short-Lived Effector T Cells In Vivo Effector Function and Accumulation of Adoptive Immunotherapy by Enhancing the Tumor-Specific T Cells Improves Efficacy of Domain-Containing Phosphatase 1 in Abrogation of Src Homology Region 2

  2012cites this paper
• Trial Watch

  2012cites this paper
• TCRs Used in Cancer Gene Therapy Cross-React with MART-1/Melan-A Tumor Antigens via Distinct Mechanisms

  2011cites this paper
• Current status and future applications of cellular therapies for cancer.

  2011cites this paper
• Engineering T Cells Specific for a Dominant Severe Acute Respiratory Syndrome Coronavirus CD8 T Cell Epitope

  2011cites this paper
• Application of Human Pluripotent Stem Cells in T Cell Based Cancer Immunotherapy.

  2011cites this paper
• Antigens via Distinct Mechanisms Cross-React with MART-1/Melan-A Tumor TCRs Used in Cancer Gene Therapy

  2011cites this paper
• Engineering T Cells Specific for a Dominant Severe Acute Respiratory Syndrome Coronavirus CD8 T Cell Epitope (cid:1)

  2011cites this paper
• Assessment of immunological biomarkers in patients with advanced cancer treated by personalized peptide vaccination

  2010cites this paper
• CD4+CD25− T Cells Transduced to Express MHC Class I-Restricted Epitope-Specific TCR Synthesize Th1 Cytokines and Exhibit MHC Class I-Restricted Cytolytic Effector Function in a Human Melanoma Model1

  2008cites this paper